Total Payments
$42,787
2024 Payments
$1,238
Companies
26
Transactions
143
Medicare Patients
1,131
Medicare Billing
$239,743
Payment Breakdown by Category
Consulting$35,972 (84.1%)
Food & Beverage$4,845 (11.3%)
Travel$1,731 (4.0%)
Other$181.50 (0.4%)
Education$57.49 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $35,972 | 9 | 84.1% |
| Food and Beverage | $4,845 | 120 | 11.3% |
| Travel and Lodging | $1,731 | 10 | 4.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $100.00 | 1 | 0.2% |
| Debt forgiveness | $81.50 | 1 | 0.2% |
| Education | $57.49 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $38,296 | 62 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,414 | 12 | $0 (2024) |
| Merck Sharp & Dohme LLC | $972.41 | 14 | $0 (2024) |
| Arteriocyte Medical Systems, Inc. | $303.39 | 1 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $303.26 | 12 | $0 (2024) |
| Medtronic, Inc. | $226.69 | 2 | $0 (2023) |
| United Therapeutics Corporation | $182.99 | 4 | $0 (2021) |
| PFIZER INC. | $176.36 | 4 | $0 (2024) |
| Edwards Lifesciences Corporation | $124.55 | 1 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $115.00 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,238 | 34 | Abbott Laboratories ($352.56) |
| 2023 | $18,128 | 22 | Abbott Laboratories ($17,671) |
| 2022 | $675.41 | 12 | Abbott Laboratories ($657.17) |
| 2021 | $18,096 | 16 | Abbott Laboratories ($17,934) |
| 2020 | $1,219 | 10 | Abbott Laboratories ($1,036) |
| 2019 | $1,279 | 19 | Merck Sharp & Dohme Corporation ($843.29) |
| 2018 | $514.71 | 16 | Abbott Laboratories ($208.22) |
| 2017 | $1,637 | 14 | Novartis Pharmaceuticals Corporation ($1,319) |
All Payment Transactions
143 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: Cardiology | ||||||
| 11/29/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Heart Failure | ||||||
| 11/15/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Heart Failure | ||||||
| 11/13/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/16/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/10/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $30.96 | General |
| Category: Cardiology | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/02/2024 | ENDOTRONIX, INC. | CORDELLA PULOMONARY ARTERY PRESSURE SENSOR (Device) | Food and Beverage | Cash or cash equivalent | $28.47 | General |
| Category: HEART FAILURE | ||||||
| 09/27/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Heart Failure | ||||||
| 09/17/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/09/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Heart Failure | ||||||
| 08/23/2024 | Celgene Corporation | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.48 | General |
| Category: Cardiovascular | ||||||
| 08/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/14/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Cardiology | ||||||
| 08/07/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.65 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/25/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $124.55 | General |
| 07/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: IMMUNOLOGY | ||||||
| 06/27/2024 | Arteriocyte Medical Systems, Inc. | Magellan (Device) | Food and Beverage | Cash or cash equivalent | $303.39 | General |
| Category: Orthopedics | ||||||
| 06/24/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $172.31 | General |
| Category: Heart Failure | ||||||
| 06/21/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.62 | General |
| Category: Cardiovascular | ||||||
| 05/31/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Heart Failure | ||||||
| 05/24/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/17/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.02 | General |
| Category: Cardiovascular | ||||||
| 04/12/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.12 | General |
| Category: Cardiovascular | ||||||
| 04/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 266 | 473 | $426,033 | $63,514 |
| 2022 | 9 | 326 | 527 | $419,313 | $64,760 |
| 2021 | 9 | 301 | 542 | $424,560 | $67,233 |
| 2020 | 7 | 238 | 414 | $262,083 | $44,236 |
Total Patients
1,131
Total Services
1,956
Medicare Billing
$239,743
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 62 | 154 | $204,050 | $30,725 | 15.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 49 | 106 | $68,515 | $11,716 | 17.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 73 | 122 | $63,350 | $10,686 | 16.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 16 | $23,038 | $2,576 | 11.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 18 | $19,255 | $2,079 | 10.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 14 | $10,940 | $1,691 | 15.5% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 11 | 12 | $20,720 | $1,526 | 7.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 13 | 14 | $7,070 | $1,266 | 17.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 17 | $9,095 | $1,250 | 13.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 51 | 112 | $148,400 | $23,427 | 15.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 47 | 113 | $64,975 | $10,834 | 16.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 73 | 105 | $54,040 | $9,503 | 17.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 48 | 51 | $55,333 | $6,601 | 11.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 12 | 29 | $19,720 | $4,041 | 20.5% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2022 | 19 | 19 | $29,165 | $2,516 | 8.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 14 | 22 | $11,110 | $2,048 | 18.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 32 | $12,900 | $2,038 | 15.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 12 | $8,490 | $1,741 | 20.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 14 | 20 | $10,700 | $1,353 | 12.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 11 | 12 | $4,480 | $658.12 | 14.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 49 | 133 | $169,195 | $28,035 | 16.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 82 | 135 | $68,470 | $12,444 | 18.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 41 | 123 | $67,365 | $11,891 | 17.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 43 | 45 | $47,330 | $5,553 | 11.7% |
| 93451 | Insertion of catheter for diagnostic evaluation of right heart structures | Facility | 2021 | 19 | 20 | $30,700 | $2,721 | 8.9% |
About Dr. Sandhya Murthy, M.D
Dr. Sandhya Murthy, M.D is a Internal Medicine healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2009. The National Provider Identifier (NPI) number assigned to this provider is 1720213572.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sandhya Murthy, M.D has received a total of $42,787 in payments from pharmaceutical and medical device companies, with $1,238 received in 2024. These payments were reported across 143 transactions from 26 companies. The most common payment nature is "Consulting Fee" ($35,972).
As a Medicare-enrolled provider, Murthy has provided services to 1,131 Medicare beneficiaries, totaling 1,956 services with total Medicare billing of $239,743. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Bronx, NY
- Active Since 05/22/2009
- Last Updated 05/22/2009
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1720213572
Products in Payments
- MitraClip System (Device) $17,869
- MITRACLIP (Device) $17,565
- ENTRESTO (Drug) $1,374
- Mitra Clip system (Device) $1,011
- MK-1242 (Drug) $843.29
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $576.06
- CARDIOMEMS (Device) $540.13
- Magellan (Device) $303.39
- HeartMate 3 Left Ventricular Dev (Device) $234.56
- ENDURANT IIS (Device) $226.69
- ELIQUIS (Drug) $223.68
- Circulatory Support (Device) $209.71
- OPSUMIT (Drug) $156.49
- HeartMate (Device) $142.16
- VERQUVO (Drug) $129.12
- NUEDEXTA (Drug) $115.00
- CardioMEMS HF System (Device) $96.81
- OPSUMIT MACITENTAN (Drug) $91.53
- ORENITRAM (Drug) $82.99
- None (Device) $81.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bronx
Timothy Kanter, M.d, M.D
Internal Medicine — Payments: $865,160
Internal Medicine $865,160
Dr. Jason Leider, M.d, M.D
Internal Medicine — Payments: $759,257
Internal Medicine $759,257
Bulent Atac, Md, MD
Internal Medicine — Payments: $654,500
Internal Medicine $654,500
Shervin Mortazavi, M.d, M.D
Internal Medicine — Payments: $402,598
Internal Medicine $402,598
Dr. Elizabeth Jenny-Avital
Internal Medicine — Payments: $176,355
Internal Medicine $176,355
Vivek Gumaste, M.d, M.D
Internal Medicine — Payments: $163,229
Internal Medicine $163,229